Negocio

Bristol Myers adds $2 billion to share buyback program

Bristol Myers Squibb Co.
BMY,
+0.21%

said Monday its board has approved an additional $2 billion of share buybacks, bringing the company’s full authorization to about $6.4 billion. Shares rose 1% premarket, but have fallen 3% in the last 12 months, while the S&P 500
SPX,
+0.55%

has gained 17%.

Art铆culos relacionados

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close